STEWART ABBOT, CDO at Fate Therapeutics, holds 64.92K shares in Fate Therapeutics (Ticker: FATE), holds ― shares in Adicet Bio (Ticker: ACET), holds ― shares in Turnstone Biologics Corp. (Ticker: TSBX). Most recently, STEWART ABBOT Bought ― shares of Fate Therapeutics on May 16, 2018 for an estimated value of 139.41K.